Regeneron Pharmaceuticals | Aktiver



Assets Lave om Dato
AbbVie USD 135.16B 8.26B 2024-12
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Astellas Pharma JPY 3.34T 112.09B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Incyte USD 5.75B 305.04M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 193.67B 13.57B 2025-03
Kyowa Hakko Kirin JPY 1.02T 48.08B 2025-03
Merck USD 117.11B 426M 2024-12
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 132.8B 3.04B 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Regeneron Pharmaceuticals Aktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.